Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Prostatic Neoplasms 3Muscle Weakness 2Motor Activity 2Sedentary Behavior 1Sarcopenia 1Muscular Atrophy 1Head and Neck Neoplasms 1Fatigue 1Cachexia 1Body Weight Changes 1Anorexia 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Creatine × Clear all
NCT07372144 2026-01-28

IARA

D'Or Institute for Research and Education

Phase 3 Not yet recruiting
227 enrolled
Breast

Breast Neoplasms

NCT06395506 2025-12-24

THRIVE

The University of Texas Medical Branch, Galveston

Phase NA Recruiting
60 enrolled
Breast

Breast Neoplasms, Motor Activity, Muscle Weakness

NCT05878106 2024-05-09

CaRTiC

University of Deusto

Phase NA Recruiting
120 enrolled
Breast

Breast Neoplasms

NCT04207359 2023-07-25

Effects of Creatine Supplementation in Breast Cancer Survivors

The University of Texas Health Science Center at San Antonio

Phase NA Completed
20 enrolled
Breast

Breast Neoplasms, Motor Activity, Muscular Atrophy, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡